175 related articles for article (PubMed ID: 26377788)
1. Contractile function assessment by intraventricular balloon alters the ability of regional ischaemia to evoke ventricular fibrillation.
Wilder CD; Masoud R; Yazar D; O'Brien BA; Eykyn TR; Curtis MJ
Br J Pharmacol; 2016 Jan; 173(1):39-52. PubMed ID: 26377788
[TBL] [Abstract][Full Text] [Related]
2. Inadequate ischaemia-selectivity limits the antiarrhythmic efficacy of mibefradil during regional ischaemia and reperfusion in the rat isolated perfused heart.
Farkas A; Qureshi A; Curtis MJ
Br J Pharmacol; 1999 Sep; 128(1):41-50. PubMed ID: 10498833
[TBL] [Abstract][Full Text] [Related]
3. Anion manipulation, a novel antiarrhythmic approach: mechanism of action.
Curtis MJ; Garlick PB; Ridley PD
J Mol Cell Cardiol; 1993 Apr; 25(4):417-36. PubMed ID: 8393492
[TBL] [Abstract][Full Text] [Related]
4. Facilitation of ischaemia-induced ventricular fibrillation by catecholamines is mediated by β
Wilder CDE; Pavlaki N; Dursun T; Gyimah P; Caldwell-Dunn E; Ranieri A; Lewis HR; Curtis MJ
Br J Pharmacol; 2018 May; 175(10):1669-1690. PubMed ID: 29473948
[TBL] [Abstract][Full Text] [Related]
5. Feeding the fibrillating heart: Dichloroacetate improves cardiac contractile dysfunction following VF.
Azam MA; Wagg CS; Massé S; Farid T; Lai PF; Kusha M; Asta J; Jaimes R; Kuzmiak-Glancy S; Kay MW; Lopaschuk GD; Nanthakumar K
Am J Physiol Heart Circ Physiol; 2015 Nov; 309(9):H1543-53. PubMed ID: 26342067
[TBL] [Abstract][Full Text] [Related]
6. Absolute beat-to-beat variability and instability parameters of ECG intervals: biomarkers for predicting ischaemia-induced ventricular fibrillation.
Sarusi A; Rárosi F; Szűcs M; Csík N; Farkas AS; Papp JG; Varró A; Forster T; Curtis MJ; Farkas A
Br J Pharmacol; 2014 Apr; 171(7):1772-82. PubMed ID: 24417376
[TBL] [Abstract][Full Text] [Related]
7. Characterisation of mexiletine's translational therapeutic index for suppression of ischaemia-induced ventricular fibrillation in the rat isolated heart.
Hesketh LM; Wilder CDE; Ranadive NN; Lytra G; Qazimi P; Munro JS; Ahdi N; Curtis MJ
Sci Rep; 2020 May; 10(1):8397. PubMed ID: 32439959
[TBL] [Abstract][Full Text] [Related]
8. Tacrine inhibits ventricular fibrillation induced by ischaemia and reperfusion and widens QT interval in rat.
Rees SA; Curtis MJ
Cardiovasc Res; 1993 Mar; 27(3):453-8. PubMed ID: 8490946
[TBL] [Abstract][Full Text] [Related]
9. Selective IK blockade as an antiarrhythmic mechanism: effects of UK66,914 on ischaemia and reperfusion arrhythmias in rat and rabbit hearts.
Rees SA; Curtis MJ
Br J Pharmacol; 1993 Jan; 108(1):139-45. PubMed ID: 8428204
[TBL] [Abstract][Full Text] [Related]
10. Effects of glibenclamide on ventricular arrhythmias and cardiac function in ischaemia and reperfusion in isolated rat heart.
Bril A; Laville MP; Gout B
Cardiovasc Res; 1992 Nov; 26(11):1069-76. PubMed ID: 1291084
[TBL] [Abstract][Full Text] [Related]
11. Feasibility of targeting ischaemia-related ventricular arrhythmias by mimicry of endogenous protection by endocannabinoids.
Andrag E; Curtis MJ
Br J Pharmacol; 2013 Aug; 169(8):1840-8. PubMed ID: 23713981
[TBL] [Abstract][Full Text] [Related]
12. Anion manipulation: a new antiarrhythmic approach. Action of substitution of chloride with nitrate on ischemia- and reperfusion-induced ventricular fibrillation and contractile function.
Ridley PD; Curtis MJ
Circ Res; 1992 Apr; 70(4):617-32. PubMed ID: 1551189
[TBL] [Abstract][Full Text] [Related]
13. The isolated blood-perfused rat heart: an inappropriate model for the study of ischaemia- and infarction-related ventricular fibrillation.
Clements-Jewery H; Hearse DJ; Curtis MJ
Br J Pharmacol; 2002 Dec; 137(7):1089-99. PubMed ID: 12429582
[TBL] [Abstract][Full Text] [Related]
14. Effects of mibefradil, a novel calcium channel blocking agent with T-type activity, in acute experimental myocardial ischemia: maintenance of ventricular fibrillation threshold without inotropic compromise.
Muller CA; Opie LH; McCarthy J; Hofmann D; Pineda CA; Peisach M
J Am Coll Cardiol; 1998 Jul; 32(1):268-74. PubMed ID: 9669280
[TBL] [Abstract][Full Text] [Related]
15. Susceptibility to ischemia-induced ventricular fibrillation in isolated female rat hearts varies moderately with estrous cycle stage.
Hatcher AS; Clements-Jewery H
J Pharmacol Toxicol Methods; 2013; 67(3):134-9. PubMed ID: 23357189
[TBL] [Abstract][Full Text] [Related]
16. Left regional cardiac perfusion in vitro with platelet-activating factor, norepinephrine and K+ reveals that ischaemic arrhythmias are caused by independent effects of endogenous "mediators" facilitated by interactions, and moderated by paradoxical antagonism.
Baker KE; Curtis MJ
Br J Pharmacol; 2004 May; 142(2):352-66. PubMed ID: 15066909
[TBL] [Abstract][Full Text] [Related]
17. Development and characterization of a mouse in vitro model of ischaemia-induced ventricular fibrillation.
Stables CL; Curtis MJ
Cardiovasc Res; 2009 Jul; 83(2):397-404. PubMed ID: 19228704
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological analysis in rat of the role of the ATP-sensitive potassium channel as a potential target for antifibrillatory intervention in acute myocardial ischaemia.
Rees SA; Curtis MJ
J Cardiovasc Pharmacol; 1995 Aug; 26(2):280-8. PubMed ID: 7475053
[TBL] [Abstract][Full Text] [Related]
19. Opposite change with ischaemia in the antifibrillatory effects of class I and class IV antiarrhythmic drugs resulting from the alteration in ion transmembrane exchanges related to depolarization.
Aupetit JF; Bui-Xuan B; Kioueh I; Loufoua J; Frassati D; Timour Q
Can J Physiol Pharmacol; 2000 Mar; 78(3):208-16. PubMed ID: 10721812
[TBL] [Abstract][Full Text] [Related]
20. Protection by cimetidine, but not ranitidine, implies that H2 receptors do not mediate arrhythmogenesis in a rat model of regional ischaemia and reperfusion in vitro.
Banning MM; Curtis MJ
Cardiovasc Res; 1995 Nov; 30(5):705-10. PubMed ID: 8595616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
